Better Buy: Celgene Corporation Vs. Bristol-myers Squibb

Investors haven't been too enamored with Celgene (NASDAQ: CELG) and Bristol-Myers Squibb (NYSE: BMY) lately. Both have super-successful cancer drugs and are making plenty of money. However, neither stock has performed very well so far in 2017.Which of these two drug stocks is the better pick for long-term investors? Here's how Celgene and Bristol-Myers Squibb compare.Image source: Getty Images.Continue reading

BING NEWS:
  • Novartis nominates former Bristol Myers CEO Giovanni Caforio as its new chair. Will M&A deals follow?
    Giovanni Caforio, M.D., is lining up a new gig soon after handing all his Bristol Myers Squibb leadership roles in March. | Giovanni Caforio, M.D., is lining up a new gig soon after handing all his ...
    04/22/2024 - 7:44 pm | View Link
  • With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
    Bristol Myers Squibb was the first major biopharma company to take notice of innovative cell therapy contract manufacturer Cellares, participating to a $255 million series C funding round in August | ...
    04/22/2024 - 4:10 am | View Link
  • 5 Crash-Proof Stocks to Buy Immediately
    InvestorPlace - Stock Market News, Stock Advice & Trading Tips In February, I recommended five one-month momentum plays to buy as Bitcoin ...
    04/22/2024 - 1:00 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News